Marktanteil von Antibiotikaresistenzen undWachstumsanalysebericht
Market Research Report

Globaler Marktbericht zur AntibiotikaresistenzDurch Krankheit (CUTI (Complicated Urinary).Traktinfektionen), CDI (Clostridioides Difficile).Infektion), ABSSSI (Akute bakterielle Haut).und Hautstrukturinfektionen), HABP(Hospital-Acquired Bacterial Pneumonia), CABP (Community-AcquiredLungenentzündung), cIAI (komplizierte intraabdominale Infektion),BSI (Blutstrominfektion)), durch Krankheitserreger(E. coli, K. Pneumoniae, P.Aeruginosa, S. Aureus, A. Baumannii,S. Pneumoniae, H. Influenzae, C.Difficile, E. Faecium), durch DrogeKlasse (Oxazolidinone, Lipoglycopeptide, Tetracycline, Kombination).Therapien, Cephalosporine, andere), nach MechanismusWirkungsweise (Proteinsyntheseinhibitoren,Zellwandsynthese-Inhibitoren, RNASyntheseinhibitoren, DNA-Syntheseinhibitoren,Andere), nach Vertriebskanal (KrankenhausApotheken, Einzelhandelsapotheken, Online-Apotheken)Und nach Regionen – IndustrieTrends, Größe, Anteil, Wachstum, Schätzungund Prognose, 2023–2032, 2023-2032

July 2024

Frequently Asked Questions (FAQs) about this Report

For the year 2023, the Global Market size for Antibiotic Resistance Market was valued at USD 9.24 Billion.

The Global Antibiotic Resistance Market growth is estimated to be close to 5.8% between 2024 and 2032.

In the Global Antibiotic Resistance Market, North America holds the largest market share.

Global Antibiotic Resistance Market Report is segmented By Disease (CUTI (Complicated Urinary Tract Infections), CDI (Clostridioides Difficile Infection), ABSSSI (Acute Bacterial Skin And Skin Structure Infections), HABP (Hospital-Acquired Bacterial Pneumonia), CABP (Cmmunity-Acquired Pneumonia), cIAI (Complicated Intra-Abdominal Infection), BSI (Bloodstream Infection)), By Pathogen (E. coli, K. Pneumoniae, P. Aeruginosa, S. Aureus, A. Baumannii, S. Pneumoniae, H. Influenzae, C. Difficile, E. Faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The leading players in the global Antibiotic Resistance market are Melinta Therapeutics, Basilea Pharmaceutica Ltd., Tetraphase Pharmaceuticals, Theravance Biopharma, Wockhardt, Paratek Pharmaceuticals Inc., Seres Therapeutics, Achaogen Inc., Entasis Therapeutics, AbbVie, Merck & Co. Inc.
Choose your Buying Option
Buy Now
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Request for Special Pricing
Objectives of Study
  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments
Why Choose Us
  • Client First Policy
  • Excellent Quality
  • After Sales Support
  • 24/7 Email Support

Key questions answered by the report

  • What is the current market size and trends?
  • What will be the market size during the forecast period?
  • How various market factors such as a driver, restraints, and opportunity impact the market?
  • What are the dominating segment and region in the market and why

Need specific market information?

  • Ask for free product review call with the author
  • Share your specific research requirments for a customized report
  • Request for due diligence and consumer centric studies
  • Request for study updates, segment specific and country level reports
  • Follow Us



© , All Rights Reserved, Value Market Research